ARCHIVES

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

This article is from The Cancer Letter archive.

Vol. 21 No. 47 | December 8, 1995

Download PDF Visit The Full Archive

Related Articles

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

March 2, 2001

Montefore Oncology Dept. Writes In Support of Peter Wiernik

November 12, 1993

In Brief: Lasker awards Recognizes Six Scientists; NCAB Honors Vande Woude for Work At NCI

October 1, 1999

House Subcommittee Passes Bush Request for NIH, NCI Budgets.

June 9, 2006

NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.

January 30, 2004

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010